Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aurinia Pharm Ord 14315 - 118 AVENUE SUITE 140 EDMONTON A0 T5L 4S6 CAN

www.auriniapharma.com Employees: 130 P: 250-744-2487 F: 604-369-4115

Sector:

Medical

Description:

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Key Statistics

Overview:

Market Capitalization, $K 2,145,712
Enterprise Value, $K 2,062,282
Shares Outstanding, K 131,841
Annual Sales, $ 235,130 K
Annual Net Income, $ 5,750 K
Last Quarter Sales, $ 73,470 K
Last Quarter Net Income, $ 31,550 K
EBIT, $ 80,110 K
EBITDA, $ 99,560 K
60-Month Beta 1.42
% of Insider Shareholders 12.20%
% of Institutional Shareholders 36.83%
Float, K 115,756
% Float 87.80%
Short Interest 8,436
Short Float 6.40%
Short Volume Ratio 0.66

Growth:

1-Year Return 81.24%
3-Year Return 276.74%
5-Year Return 17.68%
5-Year Revenue Growth 73,378.13%
5-Year Earnings Growth 117.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.23 on 11/04/25
Next Earnings Date 02/26/26
Earnings Per Share ttm 0.64
EPS Growth vs. Prev Qtr 43.75%
EPS Growth vs. Prev Year 130.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/08/13

AUPH Ratios

Ratio
Price/Earnings ttm 25.33
Price/Earnings forward 20.92
Price/Earnings to Growth N/A
Return-on-Equity % 25.19%
Return-on-Assets % 17.25%
Profit Margin % 2.45%
Debt/Equity 0.00
Price/Sales 9.09
Price/Cash Flow 52.56
Price/Book 5.84
Book Value/Share 2.77
Interest Coverage 2.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar